Novel o-phosphoserine export protein and the method of producing o-phosphoserine using the same

US2016115507A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016115507-A1
Application numberUS-201414890423-A
CountryUS
Kind codeA1
Filing dateMay 9, 2014
Priority dateMay 10, 2013
Publication dateApr 28, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a novel isolated polypeptide having the ability to export O-phosphoserine (OPS) that is a precursor of L-cysteine, a vector comprising the polynucleotide, an OPS-producing microorganism having enhanced activity of the polypeptide, a method of producing OPS using the microorganism, and a method for preparing cysteine or its derivatives, which comprises reacting OPS, produced by the above method, with a sulfide in the presence of O-phosphoserine sulfhydrylase (OPSS) or a microorganism that expresses OPSS.

First claim

Opening claim text (preview).

1 . A method for producing O-phosphoserine (OPS), comprising culturing an O-phosphoserine-producing microorganism having enhanced activity of a polypeptide that has an amino acid sequence of SEQ ID NO: 1 or 2 and has O-phosphoserine exporting activity. 2 . The method according to claim 1 , wherein the O-phosphoserine-producing microorganism further has reduced activity of endogenous phosphoserine phosphatase. 3 . The method according to claim 1 , wherein the O-phosphoserine-producing microorganism further has enhanced activity of phosphoglycerate dehydrogenase or phosphoserine aminotransferase. 4 . An isolated polypeptide having an amino acid sequence of SEQ ID NO: 1 or 2 and having O-phosphoserine (OPS) exporting activity. 5 . A polynucleotide encoding the polypeptide of claim 4 . 6 . A vector comprising the polynucleotide of claim 5 . 7 . An O-phosphoserine-producing microorganism having enhanced activity of a polypeptide that has an amino acid sequence of SEQ ID NO: 1 or 2 and has O-phosphoserine exporting activity. 8 . The microorganism of claim 7 , wherein the microorganism further has reduced activity of endogenous phosphoserine phosphatase. 9 . The microorganism according to claim 7 , wherein the microorganism further has enhanced activity of phosphoglycerate dehydrogenase or phosphoserine aminotransferase. 10 . A method for producing cysteine or its derivatives, comprising the steps of: a) culturing the microorganism of claim 7 to produce O-phosphoserine (OPS); and b) reacting the O-phosphoserine, produced in step a), with a sulfide in the presence of O-phosphoserine sulfhydrylase (OPSS) or a microorganism that expresses OPSS. 11 . The method according to claim 10 , wherein the sulfide is one or more selected from the group consisting of Na 2 S, NaSH, (NH 4 ) 2 S, H 2 S and Na 2 S 2 O 3 . 12 . A method for producing cysteine or its derivatives, comprising the steps of: a) culturing the microorganism of claim 8 to produce O-phosphoserine (OPS); and b) reacting the O-phosphoserine, produced in step a), with a sulfide in the presence of O-phosphoserine sulfhydrylase (OPSS) or a microorganism that expresses OPSS. 13 . The method according to claim 12 , wherein the sulfide is one or more selected from the group consisting of Na 2 S, NaSH, (NH 4 ) 2 S, H 2 S and Na 2 S 2 O 3 . 14 . A method for producing cysteine or its derivatives, comprising the steps of: a) culturing the microorganism of claim 9 to produce O-phosphoserine (OPS); and b) reacting the O-phosphoserine, produced in step a), with a sulfide in the presence of O-phosphoserine sulfhydrylase (OPSS) or a microorganism that expresses OPSS. 15 . The method according to claim 14 , wherein the sulfide is one or more selected from the group consisting of Na 2 S, NaSH, (NH 4 ) 2 S, H 2 S and Na 2 S 2 O 3 .

Assignees

Inventors

Classifications

  • C12P13/12Primary

    Methionine; Cysteine; Cystine · CPC title

  • Alanine; Leucine; Isoleucine; Serine; Homoserine · CPC title

  • C07K14/245Primary

    Escherichia (G) · CPC title

  • DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • from bacteria · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016115507A1 cover?
The present invention relates to a novel isolated polypeptide having the ability to export O-phosphoserine (OPS) that is a precursor of L-cysteine, a vector comprising the polynucleotide, an OPS-producing microorganism having enhanced activity of the polypeptide, a method of producing OPS using the microorganism, and a method for preparing cysteine or its derivatives, which comprises reacting O…
Who is the assignee on this patent?
Cj Cheiljidang Corp, Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12P13/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).